RepliGut® for Drug Disposition (DMPK)

About Altis Biosystems

Altis Biosystems is a private, pre-clinical stage company pioneering human-relevant intestinal epithelial cell models to bridge the gap between traditional cell lines, animal studies, and human clinical outcomes. Their core technology, the RepliGut® Systems, provides pharmaceutical and biotech researchers with scalable, reproducible platforms for assessing drug-induced GI toxicity, intestinal barrier function, inflammatory response, and drug disposition. By offering both kits and contract research services, Altis aims to de-risk drug development pipelines, accelerate timelines, and reduce reliance on animal models, positioning itself as a critical enabler in the growing market for predictive human biology models.

Therapeutic Areas